Trial Profile
Efficacy and safety of the new oral anticoagulants (NOACS) rivaroxaban in the treatment of venous thromboembolism in gastrointestinal (GI) oncology patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thrombosis
- Focus Adverse reactions; Therapeutic Use
- 04 Apr 2016 New trial record